Physician
Elliott I. Greenspan, D.O., P.C. & Associates
Elliott I. Greenspan, D.O., P.C. & Associates was paid $291K by Medicaid between Jan 2018 and Dec 2022, across 33 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 65% of everything it billed.
33Billing provider infoELLIOTT I. GREENSPAN, D.O., P.C. & ASSOCIATES
FARMINGTON HILLS, MI 48336
FARMINGTON HILLS, MI 48336
33aNPI1063577641assigned 12/26/2006
33bProvider typeInternal Medicine Physician
28Total paid$291K
24GClaims21,528
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2022
Compared with peers
Next to other Internal Medicine Physician providers in Michigan
Rank by total paid#250 of 816
Median peer was paid$70K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,975 | $222K | |
| 2019 | 4,482 | $64K | |
| 2022 | 71 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 65% | 2,678 | 2,431 | $190K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 1,400 | 1,249 | $64K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 587 | 547 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 845 | 802 | $5K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.6% | 61 | 58 | $5K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.4% | 48 | 47 | $4K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.3% | 71 | 12 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 69 | 68 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 290 | 276 | $2K |
| 93000 | <1% | 141 | 138 | $1K | |
| 99406 | <1% | 166 | 152 | $1K | |
| 81002 | <1% | 602 | 567 | $1K |
21 more codes
| 90686 | <1% | 57 | $973.20 | |
| 90682 | <1% | 20 | $720.00 | |
| 82962 | <1% | 321 | $693.25 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 365 | $679.67 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 78 | $455.74 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 32 | $402.34 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 250 | $378.69 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 16 | $261.89 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 18 | $229.31 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12 | $20.97 |
| 1036F | 0% | 1,708 | $0.00 | |
| 1125F | 0% | 560 | $0.00 | |
| 3080F | 0% | 251 | $0.00 | |
| 1034F | 0% | 1,380 | $0.00 | |
| 3079F | 0% | 743 | $0.00 | |
| 3075F | 0% | 522 | $0.00 | |
| 1000F | 0% | 259 | $0.00 | |
| 3074F | 0% | 2,157 | $0.00 | |
| 3077F | 0% | 398 | $0.00 | |
| 1159F | 0% | 3,461 | $0.00 | |
| 3078F | 0% | 1,962 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGREENSPAN, ELLIOTT (CEO)